Literature DB >> 2143585

Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin.

C V Clevenger1, D H Russell, P M Appasamy, M B Prystowsky.   

Abstract

The requirement for prolactin in interleukin 2-driven T-cell proliferation was evaluated. Addition of an anti-prolactin antiserum resulted in the specific inhibition of T-cell proliferation in a time- and dose-dependent manner. Synthesis of prolactin and its mRNA, however, did not occur during interleukin 2 stimulation. Instead, previously internalized prolactin, presumably from fetal bovine serum, appears to serve as the source of prolactin under serum-free conditions. A 7-fold increase in a prolactin receptor occurred as a function of cell cycle progression; accumulation of a 1.6-kilobase prolactin receptor mRNA increased approximately 2-fold. Interleukin 2 stimulation induced the translocation of prolactin into the nucleus and prolactin receptor to the nuclear periphery. These data indicate that extracellular prolactin is requisite for T-cell proliferation and suggest that the effects of prolactin are exerted in the nucleus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143585      PMCID: PMC54554          DOI: 10.1073/pnas.87.16.6460

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Inhibition of lymphocyte proliferation by antibodies to prolactin.

Authors:  D P Hartmann; J W Holaday; E W Bernton
Journal:  FASEB J       Date:  1989-08       Impact factor: 5.191

2.  Anti-growth action on mouse mammary and prostate glands of a monoclonal antibody to prolactin receptor.

Authors:  J F Sissom; M L Eigenbrodt; J C Porter
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

3.  Incorporation of regulatory peptide hormones by individual cells of the adrenal cortex: prolactin-adrenocorticotrophin differences.

Authors:  J M Nolin
Journal:  Peptides       Date:  1980       Impact factor: 3.750

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine.

Authors:  D H Russell; R Kibler; L Matrisian; D F Larson; B Poulos; B E Magun
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

6.  Intracellular prolactin in rat corpus luteum and adrenal cortex.

Authors:  J M Nolin
Journal:  Endocrinology       Date:  1978-02       Impact factor: 4.736

7.  Autocrine stimulation of Nb2 cell proliferation by secreted, but not intracellular, prolactin.

Authors:  J A Davis; D I Linzer
Journal:  Mol Endocrinol       Date:  1988-08

8.  Regulation of humoral immunity in rats by pituitary hormones.

Authors:  I Berczi; E Nagy; K Kovacs; E Horvath
Journal:  Acta Endocrinol (Copenh)       Date:  1981-12

9.  Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2.

Authors:  L M Neckers; J Cossman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

Review 10.  Interrelation of the avian immune and neuroendocrine systems.

Authors:  B Glick
Journal:  J Exp Zool       Date:  1984-12
View more
  23 in total

1.  Prolactin-regulated pim-1 transcription: identification of critical promoter elements and Akt signaling.

Authors:  Nithya Krishnan; Huiqi Pan; Donna J Buckley; Arthur Buckley
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

2.  Meta-analysis of associations between functional prolactin -1149 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Young Ho Lee; Sang-Cheol Bae; Gwan Gyu Song
Journal:  Clin Rheumatol       Date:  2015-02-28       Impact factor: 2.980

Review 3.  [Stress and the immune system].

Authors:  M Schedlowski; R E Schmidt
Journal:  Naturwissenschaften       Date:  1996-05

4.  Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cells.

Authors:  L Matera; G Bellone; J J Lebren; P A Kelly; E L Hooghe Peters; P F Di Celle; R Foa; M Contarini; G Avanzi; V Asnaghi
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

Review 5.  The role of prolactin in the pathogenesis of autoimmune disease.

Authors:  Istvan Berczi
Journal:  Endocr Pathol       Date:  1993-12       Impact factor: 3.943

6.  Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions.

Authors:  L Matera; A Galetto; M Geuna; K Vekemans; E Ricotti; M Contarini; F Moro; G Basso
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

7.  Molecular and structural analysis of nuclear localizing anti-DNA lupus antibodies.

Authors:  M H Foster; T Kieber-Emmons; M Ohliger; M P Madaio
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

Review 8.  Central nervous system-immune system interactions: psychoneuroendocrinology of stress and its immune consequences.

Authors:  P H Black
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

9.  Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer.

Authors:  T Bauernhofer; I Kuss; U Friebe-Hoffmann; A S Baum; G Dworacki; B K Vonderhaar; T L Whiteside
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

10.  Activation of the prolactin receptor gene by promoter insertion in a Moloney murine leukemia virus-induced rat thymoma.

Authors:  C S Barker; S E Bear; T Keler; N G Copeland; D J Gilbert; N A Jenkins; R S Yeung; P N Tsichlis
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.